Rheumatoid Arthritis Clinical Trials in San Antonio

Showing 421-440 of 2,746 trials

Ketones, SGLT2, HFrEF

NCT06229678

The study team will examine the effects of elevated plasma ketone levels following initiation of SGLT2 inhibitor therapy in high-risk type 2 diabetes mellitus (T2DM) individuals with heart failure (HF) with reduced ejection fraction (HFrEF) providing an energy-rich fuel that is taken up with great avidity by the myocardium, to measure change in Left Ventricle diastolic and systolic function

Type2diabetesHeart Failure With Reduced Ejection Fraction

The University of Texas Health Science Center at San Antonio71 participantsStarted Jan 2024

San Antonio, Texas, United States

Active Not RecruitingPhase 2< 1 mile

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

NCT06001385

The goal of this clinical trial is to determine the effectiveness of Reduced Dose Post-Transplant Cyclophosphamide (PTCy) in patients with hematologic malignancies after receiving an HLA-Mismatched Unrelated Donor (MMUD) . The main question\[s\] it aims to answer are: * Does a reduced dose of PTCy reduce the occurrence of infections in the first 100 days after transplant? * Does a reduced dose of PTCy maintain the same level of protection against Graft Versus Host Disease (GvHD) as the standard dose of PTCy?

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+8 more

Center for International Blood and Marrow Transplant Research313 participantsStarted Dec 2023

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Little Rock, Arkansas, United States +29 more locations

Ketones, SGLT2, HFrEF

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

Rheumatoid Arthritis Trials in Other Cities

Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021)

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial

Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma

Aventus Thrombectomy System Pulmonary Embolism Clinical Study

Micra AV Transcatheter Pacing System Post-Approval Registry

Randomized Study of the pdSTIM™ System in Failure to Wean Mechanically Ventilated Patients

Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis

A Study of MGC026 in Participants With Advanced Solid Tumors

Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

A Study of CTD402 in T-ALL/LBL Patients

A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration

PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation

A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

Single Versus Dual Implant Fixation of Distal Femur Fractures

HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

Other Conditions in San Antonio